We find that SNAR-A gene activity consistently tracks with POLR3G gene expression levels in primary immune cell populations and cancer tissues and represents the dominant dynamic feature of both THP-1 differentiation and POLR3G disruption experiments. The gene discussed is POLR3G; the disease is cancer.